Cathie Wood acquired 13 Million Intellia Therapeutics shares worth $108 Million. That's 1.10% of their equity portfolio (28th largest holding). The investor owns 11.77% of the outstanding Intellia Therapeutics stock. The first Intellia Therapeutics trade was made in Q4 2016. Since then Cathie Wood bought shares 24 more times and sold shares on seven occasions. The investor's estimated purchase price is $430 Million, resulting in a loss of 75%.
https://www.investing.com/news/company-news/cathie-woods-ark-buys-intellia-stock-sells-tesla-and-verve-93CH-3509465
Wood added to her positions in Palantir, Archer Aviation, and Intellia Therapeutics on Monday. Palantir is one of her largest holdings, and the big data anal...
Investors looking for long-term returns should consider investing in strong buy Cathie Wood stocks this month. The ARK Invest Chief Executive Officer (CEO) g...
Moderna and Intellia have declined in the double digits over the past year.